Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Yukinori OzakiTakamichi YokoeTetsuhiro YoshinamiKazuki NozawaHiroshi NishioKenji TsuchihashiEiki IchiharaYuji MiuraMakoto EndoShingo YanoDai MaruyamaNobuyuki SusumuMunetaka TakekumaTakashi MotohashiMamoru ItoEishi BabaNobuaki OchiToshio KuboKeita UchinoTakahiro KimuraYutaro KamiyamaShinji NakaoShinobu TamuraHitomi NishimotoYasuhisa KatoAtsushi SatoToshimi TakanoPublished in: International journal of clinical oncology (2024)
Both Day 2 and Days 3-5 were weakly recommended for pegylated G-CSF administration post-chemotherapy in patients with cancer. The limited evidence highlights the need for further research to refine recommendations.